Evidence map›Paper›PMID 9858516›Full record

ArticleThe Journal of experimental medicine1998

CD5 expression is developmentally regulated by T cell receptor (TCR) signals and TCR avidity.

H S Azzam, A Grinberg, K Lui, H Shen, E W Shores, P E Love

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of experimental medicine, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 355 papers.

0numbers the graph read from it
0cells of the map it votes in
355citing papers in PubMed
4.0field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

355 citing papers in PubMed, 664 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Generation of effector CD4Stem cell reports · 2026
    Article
  5. Article
  6. Unique CD8bioRxiv : the preprint server for biology · 2026
    Article
  7. GRP75 sustains CD8Cell death and differentiation · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Antigen-specific immunotherapy with a CD4Nature communications · 2026
    Article
  15. Article
  16. Article
  17. AFrontiers in immunology · 2026
    Article
  18. Article
  19. Article
  20. Article

295 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

H S AzzamLaboratory of Mammalian Genes and Development, National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, Maryland 20892, USA.
A Grinberg
K Lui
H Shen
E W Shores
P E Love
Center for Biologics Evaluation and Research · USNational Institutes of Health · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent data indicate that the cell surface glycoprotein CD5 functions as a negative regulator of T cell receptor (TCR)-mediated signaling. In this study, we examined the regulation of CD5 surface expression during normal thymocyte ontogeny and in mice with developmental and/or signal transduction defects. The results demonstrate that low level expression of CD5 on CD4(-)CD8(-) (double negative, DN) thymocytes is independent of TCR gene rearrangement; however, induction of CD5 surface expression on DN thymocytes requires engagement of the pre-TCR and is dependent upon the activity of p56(lck). At the CD4(+)CD8(+) (double positive, DP) stage, intermediate CD5 levels are maintained by low affinity TCR-major histocompatibility complex (MHC) interactions, and CD5 surface expression is proportional to both the surface level and signaling capacity of the TCR. High-level expression of CD5 on DP and CD4(+) or CD8(+) (single positive, SP) thymocytes is induced by engagement of the alpha/beta-TCR by (positively or negatively) selecting ligands. Significantly, CD5 surface expression on mature SP thymocytes and T cells was found to directly parallel the avidity or signaling intensity of the positively selecting TCR-MHC-ligand interaction. Taken together, these observations suggest that the developmental regulation of CD5 in response to TCR signaling and TCR avidity represents a mechanism for fine tuning of the TCR signaling response.

Indexed as

Signal TransductionAnimalsAntibodiesAntigens, CDCD5 AntigensCell DifferentiationDNA-Binding ProteinsFemaleFlow CytometryGene Rearrangement, T-LymphocyteHistocompatibility Antigens Class IHistocompatibility Antigens Class IILymphocyte Specific Protein Tyrosine Kinase p56(lck)Lymphocyte SubsetsMiceMice, Inbred C57BLAntibodiesAntigens, CDCD5 AntigensDNA-Binding ProteinsHistocompatibility Antigens Class IHistocompatibility Antigens Class IILymphocyte Specific Protein Tyrosine Kinase p56(lck)Rag2 protein, mouseReceptors, Antigen, T-CellReceptors, Antigen, T-Cell, alpha-betaV(D)J recombination activating protein 2

Identifiers

PMID9858516
PMCPMC2212429
OpenAlexW2128106363

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.